Endometriosi e criopreservazione degli ovociti - SICHIG · suggerimento di cercare subito una...
Transcript of Endometriosi e criopreservazione degli ovociti - SICHIG · suggerimento di cercare subito una...
Endometriosi e criopreservazione degli
ovociti
Bergamo 27/01/2017
Prof.ssa Maria Elisabetta Coccia
Prof.Associato di Ginecologia e Ostetricia
Direttore SODc PMA – AOUCareggi
In Italy
Endometriosis.org
Fertil Steril
LEA
E’ una patologia CRONICA, PROGRESSIVA che necessita di un controllo CONTINUO da parte dello specialista per tutta la durata dell’età fertile.
Quadro normale Endometriosi anteriore
Endometriosi Posterioreendometrioma
3D CORONAL PLANE
1. endometrioma
2. Deep endometriosisPre Post
3. Infertility
4. Chronic Pelvic Pain
ENDOMETRIOSIS
DIE
ADENOMYOSIS
5. Menorragia
REDUCTION OVARIAN RESERVEPOF
Endometriosis Treatment
Medical
Surgical
IVF
Alternative medicine
Why – When –Who-
Endometriosis
&
OoocytesCriopreservation
Ovarian Damage?
Effect of the disease?
• Generally, the decline in ovarian follicles that happens throughout life does not hamper greatly the chance of conception before 37 years of age
this deterioration can take place at an earlier age in cases of ovarian endometriosis
DECLINE IN FOLLICULAR NUMBER
INCREASE IN POOR QUALITY
?
Endometrioma
– space-compression effects,
– Local reactions
– - Adverse changes in blood flow
– Both
Can reduce the amount offunctional ovarian tissue available
Surgery
- Healthy ovarian tissue excised
-Reduced ovarian volumes
- Adverse changes in blood flow
- Spontaneous ovulation < frequent -
Responsiveness to hyperstimulation <
Risks of surgical treatment of endometrioma before ART
Risks of intact endometrioma during ART
Hamdan 2015
endometrioma-related damage to ovarian reserve clinically evident in
surgically treated bilateral endometriomas
2011
2006
Mean age at menopause after surgery forbilateral endometriomas
Coccia et al. 2011
Bilateral Monolateral
Significant relationship preoperative ovarian endometriomas total diameter /age at menopauseLarger size of ovarian endometriomas
younger age at menopause onset.
not confirmed in case of unilateral ovarian endometrioma:the contralateral intact ovary might adequately compensate
The endometrioma-related damage to ovarian reserve become clinically evident in women surgically treated for
bilateral endometriomas
Coccia et al. 2011
Coccia et al 2008
Timing surgery/pregnancySurgery
• the immediate post-operative period favourable for conception (6 months)
• time-dependent diminution of fecundity for– a detrimental effect of the disease on fertility
– Patients’ age
• patients should be advised to start trying to conceive immediately after surgery
oocyte quality?
• fertilization rates, IVF cycles– Peritoneal Fluid from patients with Endometriosis may attenuate the
potential of fertilization and embryo development by altering embryo-derived EGF and IGF-I and signal transduction (Ding 2010)
– Increased fertilization rate in more advanced stages (Barnhart 2002)
• oocytes donors– Embryos derived from the ovaries of women
with endometriosis display a
reduced ability to implant (Pellicer 1994)
Endometriosis IVF-ICSI patients: 2016 SOD PMA
• 156 infertile patients with endometriosis• Mean age 33.9 yrs (22-44) (2 patients <25 years)• 120 underwent surgery for endometriosis• 10/120, 8.3%, first surgery for endometriosis younger than
23 years• Women who had their first surgery earlier showed:
– Lower ovarian reserve▪ basal FSH 20.2±15.6 vs 10.9 ±8.4, P= 0.038;▪ AMH 0,6 ±0,4 vs 2.2 ng/ml ,P=0.198)– Younger at their first visit in a ART centre
(31±7.4 vs 35.4 ±4.2 yrs , P= 0.032)
So….. real endometriosis problem exist nedded precociusdiagnosis
**Coccia et al. Unpublished
Endometriosis IVF-ICSI patients: 2016 SOD PMA
On this results nedded to preserve fertility with tissue and or oocytes vitriifcation!!!
Endometriosisand adolescence/young woman
Adolescent endometriosis is different from adult endometriosis:shorter cycles, larger ovarian endometrioma, higher dysmenorrhoea
bilateral? Patients with larger ovarian endometrioma higher probability to be re-operated and
they will develop deep endometriosis.
This should led to- follow up in adolescent (also with AMH)
-suggest OC- Counselling on future fertility
- Ovarian freezing?
SURGERY : our Results in young women
• endometriosis Clinic number of patients: 1153 (686+14deep+453amb endom (210 operated))
• endometriosis Clinic number of patientsundergoing surgery: 898
• Patients ≤24 years old: 88 (9.7%)
– Mean age 21.5±2.5 (range 12-24), median 22 years
What types of endometriosis
n. %
Ovarian endometrioma 66 75
- MonolateralRight Left
421626
- bilateral 24 27.3
Minimal mild endometriosis 8 9.1
Deep endometriosis 37 42
higher incidence of severe endometriosis Ultrasound diagnosis in young patients
>22 yrs ≤ 22 yrs P
Menarche 12.4±1.5 11.9±1.4 0.042
BMI 22.1±3.5 20.5±2.6 0.020
Period length(before surgery)
28.4±2.9 26.5±4 0.022
Flow length(before surgery)
5.1±1.8 5.4±1.7 0.322
Mean diameter ovarianendometrioma
37.1±17.9 50.3±20.1 0.027
Are younger women different from adults?
Are younger women different? Mean diameter ovarian endometrioma
• Pearson correlation -0.176, Sig (2-tailed), 0.031
L’esperienza di un centro IstituzionalePMA ETEROLOGA
• N cartelle aperte PMAe : n. 1986
• 1^ visite febbraio 2018
• 2^ visite luglio 2017
POF 18%
Età avanzata14%
Ridotta RO dopo fallimenti
26%
Donne con difetti genetici
2%
Ovociti e/o embrioni di
scarsa qualità11%
Fattoreiatrogeno
femminile 4%
Fattoremaschile severo
11%
Disfunzioneeiaculatoria
incurabile 0%
Uomini con difetti genetici
3%Infezione sess.
Trasmissibile 0%
Uomini con fattoreiatrogeno 0 %
Indicazioni cliniche
PMA Omologa – indicazione endometriosi( 01/14 – 11/16 )
• 165/1959 (8.4%)
PMA Eterologa – indicazione endometriosi(09/14 – 07/16)
• 166/1304 (12.7%)
P value 0.0001
• 153/1042 (14.7%) solo fattore femminile
P value 0.0001
Prevalenza di pazienti con endometriosi
PMAOmologan=155* PMAEterologan=153
Media±DS Media±DS Pvalue
Età(anni) 35,9±4,3 40,9±3,9 <0,001
BMI(kg/m2) 22,2±4,0 22.9±4,2 ns
AMH(ng/mL) 1,2±1,2 0,5±0,8 <0,001
FSHbasale(mUI/mL) 11,11±8,4 31,4±35,8 <0,001
Estradiolobasale
(pg/ml)
90,5±115,2 85,0±109,6 ns
TSH(mUI/mL) 1,95±1,17 1,8±0,8 ns
Ciclimestruali N=139 N=152
Regolari 86,3%(120) 63,8%(97) <0,001
Irregolari 13,7%(19) 17,8%(27) ns
Menopausa 0% 18,4%(28) <0,001
*datimancanti
Pazienti infertili con endometriosiomologa vs eterologa
Caratteristiche delle pazienti
Cicli Omologa vs Eterologa
Pazienti con endometriosi PMAOmologa
N=66
PMAEterologa
N=29
Pvalue
n(%) n(%)
Ciclisospesi 13(19,7) 1(3,5) 0,039
EmbryoTransfer(ET) 45(68,1) 28(96,5) 0,002
Beta-hCGpositive(β+) 7(10,6) 9(31) 0,014
Gravidanzebiochimiche 2(3) 1(3,4) ns
PerET 2(4,4) 1(3,6) ns
Perβ+ 2(28,6) 1(11,1) ns
Gravidanzecliniche 5(7,5) 8(27,6) 0,008
Pregnancyratepercicloiniziato 8,3% 27,6 0,008
PregnancyrateET 11,1% 28,5% 0,057
Aborti 1(1,5) 0(0) ns
GravidanzeOngoingperET 1(2,2) 4(14,3) 0,047
Parti 3(6,6) 4(14,3) ns
Bambininati
4
1p.gemellare
4
Outcome Riproduttivo: Discussione
Endometriosi Eterologa12,7 %
• Cicli Omologa vs. Eterologa
• Cicli Eterologa: Endometriosi vs. Non Endometriosi
Necessità di informazione e gestione della paziente con endometriosi sotto il profilo riproduttivo:
CONCLUSIONI:
▸ ↓ Ovociti
▸ ↓ Embryo Transfer
▸ ↓ Gravidanze
+ Favorevole
Endometriosi Omologa 8,4 %
VS.(P<0,001)
Stesso Outcome
▸ Orientare a gravidanza precoce?▸ Preservazione? ▸ Ovodonazione come possibilità
Impatto Psicologico: Discussione
Le pazienti infertili con endometriosi rispetto ai controlli:
▸ vivono la sfera emotiva e mente/corpo in modo peggiore,
attribuendo all’endometriosi un valore di possibile aggravante
▸ percepiscono il loro stato di salute più scadente
▸ sono più preoccupate per l’impatto della PMA sul proprio
corpo
L’endometriosi comporta un peggiore impatto emotivo nella donna infertile
Conclusioni:
History of cryopreservation technology
Mid-20° century cryopreservation of cellsand tissues
1953 The first human birth from frozensperm
1984 The first human birth from a frozenembryo
1986 The first human birth from oocyte
Slow freeze Vitrification ( since 1987)
The Revolution was ……
The Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology
Mature oocyte cryopreservation: a guideline
Society for Reproductive Medicine and Society for Assisted Reproductive Technology, Birmingham, AlabamaFertil Steril. 2013 Jan;99(1):37-43. doi: 10.1016/j.fertnstert.2012.09.028. Epub 2012 Oct 22
22, 2012
Oocyte cryopreservation should no longer be considered experimental
Criopreservazione di ovocitiPRO
•prelievo poco invasivo• efficacia provata
CONTRO•necessità di stimolazione ormonale
Shai E. Elizur Fertility and Sterility January 2009
oophorectomy
Ultrasound examination at our center revealed an absent right ovary and anormal-looking left ovary measuring 29 ! 19 ! 16 mm.We discussed the option of GnRH agonist (GnRHa) treatment or anothersurgery. Because of the concerns of possible further reduction in ovarianreserve related to surgery, we evaluated her ovarian reserve.Her basal serum levels of FSH, LH, and E2 on the third day of her menstrualcycle were 6.6 IU/L, 3.3 IU/L, and 122 pmol/L, respectively. However, the antralfollicle count (AFC) in the remaining ovary was only 3, suggesting diminishedovarian reserve. As she had no male partner, we counseled her on thepossibility of oocyte cryopreservation before further treatment. Oocytevitrification
Fertility preservation
PMA in AOUC 47
Regione che ascolta anche la sofferenza e da una opportunità anche nella “speranza” post cancro
Preservazione della fertilità
Toscana:Aree Prioritarie Intervento
Le aree prioritarie d’intervento possono essere individuate come segue:
• 1. Creazione di una rete multidisciplinare di specialisti per diffondere laconoscenza di questi temi ed agevolare percorsi appropriati alle pazienti,anche attraverso interventi di formazione specifica di ginecologi e oncologie dei soggetti che professionalmente sono coinvolti nella diagnostica e neltrattamento di tali patologie.
• 2. Definire percorsi appropriati di preservazione della fertilità cheincludano la raccolta e crioconservazione di cellule germinali e tessutoovarico.
• 3. Individuare opportuni centri di riferimento per macro-aree territorialiinterregionali per la raccolta e crioconservazione e stoccaggio di cellulegerminali e tessuto ovarico che costituiscano la rete di riferimento perdette pazienti
PRESERVAZIONE DELLA FERTILITA’
Affetti da neoplasie maligne
Affetti da patologie con previsione di chemio/radioterapia o immunosoppressori
Donne affette da endometriosi severa
RazionaleE’ facile evincere come la preservazione della fertilità nella giovane donna con endometriosi, spesso ancora single ( e quindi non in grado di accettare il suggerimento di cercare subito una gravidanza) possa tradursi in un risparmio per la spesa pubblica ottimizzando le possibilità di successo della PMA potendola eseguire con oociti in quantità maggiore e di quantità migliore in un periodo successivo
(A. Cobo et al. RBM online, 2012 – AMF Mohamed F&S Elsevier, 2011),
spesso caratterizzato da una riserva ovarica seriamente compromessa dalla malattia di per sé
(Marcoux et al, NEJM 1997 - Engl B and Brugger JG, Fertility 2011)
e dalla chirurgia ovarica (M. Kitajia, F&S 2011),
con importante riduzione del pregnancy rate in cicli di PMA
che in ogni caso – prima o poi - saranno garantiti dal SSN .
LOOKING FOR THE BEST ANALOGY(G. PENNINGS)
• Autodonazione di sangue per deposito preoperatorio- paziente sano al momento del prelievo- procedura ben testata ed accettata- vantaggio medico per il paziente: sicurezza- nessuna necessità di donatore- incerto utilizzo del materiale
Indicazione socialeIndicazione medica
Prelievo ovocitario per crioconservazione- paziente sano al momento del prelievo- procedura ben testata ed accettata- vantaggio medico per il paziente- nessuna necessità di donatore- incerto utilizzo del materiale
Tomei modified
Ma indispensabilità di informare
PRESERVAZIONE DELLA FERTILITÀ IN PAZIENTI DI SESSO MASCHILE
Criteri d’esclusione- uomo > 50 anni- malattie benigne/collaterali che possono interferire con le procedure collegate al prelievo degli spermatozoi/materiale testicolare.
PRESERVAZIONE DELLA FERTILITÀ IN PAZIENTI DI SESSO FEMMINILE
Crioconservazione degli ovociti Crioconservazione tessuto ovarico o di ovaio in toto
Criteri d’esclusione- età > 40 anni;- malattie benigne/collaterali che possono interferire con le procedure collegate al prelievo degli ovociti o al prelievo del tessuto
Aggiornamento del nomenclatore regionale delle prestazioni di preservazione della fertilità
COUNCELING and check Ovarian Reserve
need for early counseling regarding fertility preservation: ovarian agingrelated to advancing age and the acute damage inflicted by surgery areboth factors that can be counteracted through FPT.
➢ Counseling patients with endometriosis should highlight the advantagesof early conception that will increase success rates and may attenuatedisease progression.
➢ women should be presented with the option of ovarian sparing surgeryand the most recent techniques of cryopreservation, already widelyadopted in oncological patients:➢ freezing oocytes, embryos, or➢ ovarian tissue at a younger age
• For women with laparoscopically and histologically confirmed stage III-IV endometriosis receiving their first ICSI cycle, – serum AMH levels were significantly low only in women with a previous history of
endometrioma surgery,
– AFC was significantly lower in both groups of endometriosis with and without a previous history of endometrioma surgery compared with the control group.
• Multivariate analysis confirmed that AFC represents the most useful ovarian response marker to COS in all studied groups, as the number of mature oocytes retrieved increased with increasing AFC but decreased with increasing age
– Patients affected with severe endometriosis are at significantrisk for ovarian tissue damage, which may lead to infertility,reduced response to ovarian stimulation, and occasionally,premature ovarian failure.
– The risk for a compromised ovarian reserve in young patientsis especially high following repeated surgical intervention and inthe presence of bilateral endometriomas.
– In light of recent advances in fertility preservation techniques(FPT), such as oocytes and ovarian tissue freezing, as well astheir increasing success rates
– Personalized counseling should be offered to all patients withendometriosis taking into account age, extent of ovarianinvolvement, current ovarian reserve, previous and impendingsurgeries for endometriosis, along with current success ratesand possible risks associated with FPT
Why : ovarian reserve damage
When follow-up suggests ovarian reserve damage coming
Who-mayor risk women had surgery for
bilateral cyst and or AMH low / AFC low before 35 yrs
Endometriosis
&
OoocytesCriopreservation
Ovarian tissue cryopreservation
Ovarian tissue cryopreservation represents a validstrategy to preserve reproductive function andsteroidogenic activity in patients with a high risk ofpremature ovarian failure.
During surgery a small tissue quantity for tissue preservation?
Ovarian tissue cryopreservation (OTCP)
Ovarian tissue cryopreservation (OTCP) is currently used worldwide to preserve fertility inyoung women facing chemotherapy or radiotherapy who are at high risk of losing ovarianfunctionOTCP is also practiced in some benign conditions associated with high risk of POF[Jadoul2010].
The technique usually involves one-sidedsurgical removal of ovarian cortical tissue orcomplete oophorectomy .The harvested cortical tissue is dissected intothin (1– 2 mm) strips measuring 0.5 × 1 cm2 ,which are frozen for future transplantation.Primordial follicles are located in a poorlyvascular environment and are relativelyresistant to ischemia.
• Early diagnosis
• US in adolescents suffering from pelvic-pain/dysmenorrhoea
• Research on endometriosis in adolescents
• Counsel patients (although still not looking for a
pregnancy) with medical therapy
• patients with bilateral endometriomas
– Avoid surgery when possible giving medicalwaiting for PMA
– Medical treatment and surgical treatment to have smaller endometrioma
– Avoid to check little nodules (?)
– experienced surgeons!
– ART
– PRESERVATION SELECTED CASES
fertility preservation
(oocytes, ovarian Tissue)
Grynberg M, Benard J. Gynecologie Obste´trique & Fertilite´ (2015),
Not the same treatment for all the womenBUT now
ELEMENT TO PRESERVE FERTILITY NEEDED TO BE USED
CHRONIC PELVIC PAIN
DIE
Thank you
OVARIAN RESERVE & POF
CouncelingBilateral cyst urgeryFollicle countAMH